Seqens commissioning UK diols plant
Seqens has revealed that it is commissioning a new plant at its site, which was formerly part of Chemoxy, in Billingham, north-east England. This will make diols such as 1,2-hexanediol, 2-ethylhexylglycerin and caprylyl glycol for use in cosmetic ingredients and hand sanitisers.
The investment cost over £10 million and commercial production should start in June. It is expected to create 15 new jobs, plus further work in the global distribution chain. The site has already been producing hand sanitiser since May 2020.
“When the business was sold to French owners, one of the first things they did was approve this expansion,” said Alastair Lloyd, commercial director at Seqens’ Custom Specialties business. “We have already provided hand sanitiser to the NHS and this expansion helps continue the fight against COVID.”
This is the largest investment Seqens has made at its UK sites and will more than double its production of cosmetic ingredients. It follows on from substantial growth in demand. Diols are used in creams, lotions, cosmetics, shampoos and conditioners, among other things.